Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy

Mahshid Deldar Abad Paskeh1, Maliheh Entezari1, Courtney Clark2

  • 1Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Insights

Nanoparticles offer a promising strategy for cancer therapy by targeting autophagy, a cellular process involved in homeostasis and tumor progression. Modulating autophagy with nanoparticles can enhance chemotherapy effectiveness and reduce cancer growth.

Area of Science:

  • Biomedical Engineering
  • Cancer Research
  • Cell Biology

Background:

  • Autophagy is crucial for cellular homeostasis, involving the recycling of damaged components and degradation of toxic substances.
  • Targeting autophagy is a growing area in cancer therapy due to its dual role in promoting or inhibiting tumor progression.
  • Understanding the complex functions of autophagy in tumors is essential for effective therapeutic strategies.

Purpose of the Study:

  • To review the application of nanoparticles in targeting autophagy for cancer treatment.
  • To explore how nanocarriers can deliver autophagy regulators and chemotherapeutics for synergistic effects.
  • To discuss the potential of nanomaterials in modulating autophagy-induced apoptosis and enhancing anti-cancer therapies.

Main Methods:

  • Review of current literature on nanoparticle-mediated autophagy targeting in cancer.
  • Analysis of nanocarrier systems for delivering autophagy regulators and chemotherapeutic agents.
  • Investigation of specific nanomaterials (e.g., gold, zinc oxide, polymeric, lipid-based, carbon-based) and their impact on autophagy pathways.
  • Examination of genetic tools (siRNA, shRNA) for targeting autophagy regulatory complexes.

Main Results:

  • Nanoparticles can deliver autophagy regulators and chemotherapeutics, leading to enhanced anti-tumor effects.
  • Specific nanostructures like gold and zinc oxide nanoparticles can induce oxidative stress, promoting apoptosis and autophagy.
  • Nanoparticle-modulated autophagy potentiates the efficacy of chemotherapy drugs such as cisplatin and gefitinib.
  • Various nanomaterials can influence key autophagy regulators including ATGs, Beclin-1, and LC3-II.

Conclusions:

  • Nanoparticles represent a versatile platform for modulating autophagy in cancer treatment.
  • Targeting autophagy through nanomaterials can enhance the efficacy of existing chemotherapies and induce cancer cell death.
  • Further research into the dual role of nanomaterial-induced autophagy (pro-survival vs. pro-death) is critical for optimizing cancer therapy strategies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.8K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K